GeneDx Holdings Corp. (WGS)

Profile

Full Name

GeneDx Holdings Corp.

Ticker

NASDAQ: WGS

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

November 4, 2020

Indexes

Not included

Website

https://www.genedx.com

Employees

1000

Key Details

Price

$119.87(-0.35%)

Market cap

$3.44B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$305.45M(+50.79% YoY)

Annual EPS

-$1.94(+73.17% YoY)

PE ratio

2397.40

Next earnings date

Oct 28, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $119.87
    WGS price is $119.87

    30-Day Relative Volume

    1.08
    WGS 30-day relative volume is 1.08

    Price Performance

    Price Today change

    -0.35%
    WGS price is down -0.35% today

    Price YTD change

    +55.96%
    WGS price is up +55.96% since January 1st

    Price 1-year change

    +247.45%
    WGS price is up +247.45% year-on-year

    Price 3-year change

    +205.25%
    WGS price is up +205.25% over the past 3 years

    Price Range

    Price All-time high

    $896.94
    WGS price is currently -86.64% below its historical high of $896.94

    Price 3-year low

    $1.16
    WGS price is currently >+9900.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $3.44B
    WGS market capitalization is $3.44 billion

    Market cap 3-year change

    +660.2%
    WGS market capitalization is up +660.2% over the past 3 years

    Market cap All-time high

    $3.63B
    WGS market capitalization is currently -5.14% below its historical high of $3.63 billion

    Market cap sector rank

    86.4%
    WGS market capitalization is higher than 86.4% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +6.65%
    WGS shares outstanding is up +6.65% year-on-year

    Shares Outstanding 3-Year Change

    +149.04%
    WGS shares outstanding is up +149.04% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.63
    WGS beta is 1.63

    200-day SMA

    $83.81
    WGS price is currently +43.02% above its 200-day simple moving average

    50-day SMA

    $91.16
    WGS price is currently +31.50% above its 50-day simple moving average

    RSI

    69.62
    WGS 14-day relative strength index is 69.62

    Volume

    1.08
    WGS 30-day relative volume is 1.08

    ATR

    $6.00
    WGS average true range is $6.00

    10-day Historical Volatility

    51.93%
    WGS 10-day historical volatility is 51.93%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $305.45M
    WGS annual revenue is $305.45 million

    Revenue Analysts estimate

    $410.79M
    WGS annual revenue is currently -25.64% lower than the consensus analysts' forecast

    Revenue 1-year change

    +50.79%
    WGS annual revenue is up +50.79% year-on-year

    Revenue Sector rank

    77.41%
    WGS annual revenue is higher than 77.41% of companies in Healthcare sector

    EPS

    EPS

    -$1.94
    WGS annual earnings per share is -$1.94

    EPS Analysts estimate

    $1.74
    WGS annual earnings per share is currently -211.24% lower than the consensus analysts' forecast

    EPS 1-year change

    +73.17%
    WGS annual earnings per share is up +73.17% year-on-year

    EPS Sector rank

    37.76%
    WGS annual earnings per share is higher than 37.76% of companies in Healthcare sector

    Profit

    Gross profit

    $194.40M
    WGS annual gross profit is $194.40 million

    Gross margin

    63.64%
    WGS annual gross profit margin is 63.64%

    Operating profit

    -$23.21M
    WGS annual operating income is -$23.21 million

    Operating margin

    -7.60%
    WGS annual operating profit margin is -7.60%

    Net income

    -$52.29M
    WGS annual net profit is -$52.29 million

    Net margin

    -17.12%
    WGS annual net profit margin is -17.12%

    Expenses

    Total expenses

    $328.66M
    WGS annual total expenses is $328.66 million

    Operating expenses

    $217.61M
    WGS annual total operating expenses is $217.61 million

    Cost of goods sold

    $111.05M
    WGS annual cost of goods sold is $111.05 million

    Selling, general & administrative expenses

    $168.48M
    WGS annual SGA is $168.48 million

    Depreciation and amortization

    $21.95M
    WGS annual depreciation & amortization is $21.95 million

    Interest expense

    $0.00
    WGS annual interest expense is $0.00

    Income tax

    -$343.00K
    WGS annual income tax is -$343.00 thousand

    EBIT & EBITDA

    EBIT

    -$23.21M
    WGS annual earnings before interest & taxes is -$23.21 million

    EBITDA

    -$1.26M
    WGS annual EBITDA is -$1.26 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $464.70M
    WGS annual total assets is $464.70 million

    Non current assets

    $266.74M
    WGS annual long term assets is $266.74 million

    Current assets

    $197.97M
    WGS annual total current assets is $197.97 million

    Cash and cash equivalents

    $141.19M
    WGS annual cash & cash equivalents is $141.19 million

    Accounts receivable

    $37.43M
    WGS annual accounts receivable is $37.43 million

    Inventory

    $10.65M
    WGS annual inventory is $10.65 million

    Liabilities

    Total liabilities

    $219.46M
    WGS annual total liabilities is $219.46 million

    Long term liabilities

    $164.64M
    WGS annual total long term liabilities is $164.64 million

    Current liabilities

    $54.82M
    WGS annual total current liabilities is $54.82 million

    Accounts payable

    $7.95M
    WGS annual accounts payable is $7.95 million

    Debt

    Total debt

    $116.17M
    WGS annual total debt is $116.17 million

    Total debt 1-year change

    -2.6%
    WGS annual total debt is down -2.6% year-on-year

    Long term debt

    $112.83M
    WGS annual long term debt is $112.83 million

    Short term debt

    $3.34M
    WGS annual short term debt is $3.34 million

    Equity & Capital

    Shareholders equity

    $245.25M
    WGS annual stockholders equity is $245.25 million

    Book value

    $245.25M
    WGS annual book value is $245.25 million

    Retained earnings

    -$1.35B
    WGS annual retained earnings is -$1.35 billion

    Working capital

    $143.15M
    WGS annual working capital is $143.15 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$28.50M
    WGS annual cash flow from operations is -$28.50 million

    Cash from operations 1-year change

    +84.18%
    WGS annual cash flow from operations is up +84.18% year-on-year

    Cash from investing

    -$30.13M
    WGS annual cash flow from investing activities is -$30.13 million

    Cash from investing 1-year change

    +31.09%
    WGS annual cash flow from investing activities is up +31.09% year-on-year

    Cash from financing

    $44.16M
    WGS annual cash flow from financing activities is $44.16 million

    Cash from financing 1-year change

    -76.29%
    WGS annual cash flow from financing activities is down -76.29% year-on-year

    CAPEX

    CAPEX

    $5.49M
    WGS annual capital expenditures is $5.49 million

    CAPEX 1-year change

    -3.85%
    WGS annual capital expenditures is down -3.85% year-on-year

    Free Cash Flow

    Free cash flow

    -$33.99M
    WGS annual free cash flow is -$33.99 million

    Free cash flow 1-year change

    +81.71%
    WGS annual free cash flow is up +81.71% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    63.64%
    WGS annual gross profit margin is 63.64%

    Operating margin

    -7.60%
    WGS annual operating profit margin is -7.60%

    Net margin

    -17.12%
    WGS annual net profit margin is -17.12%

    ROA & ROE

    ROA

    -11.14%
    WGS annual return on assets is -11.14%

    ROE

    -22.10%
    WGS annual return on equity is -22.10%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    2397.40
    WGS price to earnings ratio is 2397.40

    PE ratio Sector rank

    100%
    WGS price to earnings ratio is higher than 100% of companies in Healthcare sector

    PB Ratio

    PB ratio

    12.43
    WGS price to book ratio is 12.43

    PB ratio Sector rank

    91.84%
    WGS price to book ratio is higher than 91.84% of companies in Healthcare sector

    PS Ratio

    PS ratio

    9.50
    WGS price to sales ratio is 9.50

    PS ratio Sector rank

    73.62%
    WGS price to sales ratio is higher than 73.62% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $3.42B
    WGS enterprise value is $3.42 billion

    Enterprise value Sector rank

    85.61%
    WGS enterprise value is higher than 85.61% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    112.90
    WGS EV/EBITDA is 112.90

    EV/EBITDA Sector rank

    98.76%
    WGS EV/EBITDA is higher than 98.76% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.61
    WGS annual current ratio is 3.61

    Quick ratio

    3.42
    WGS annual quick ratio is 3.42

    Leverage

    Debt to equity

    0.48
    WGS annual debt to equity ratio is 0.48

    Interest coverage ratio

    -
    WGS annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    8
    WGS piotroski f-score is 8

    Altman Z-Score

    6.20
    WGS altman z-score is 6.20

    Analyst ratings

    Recent major analysts updates

    Aug 4, 25 Piper Sandler
    Overweight
    Jul 30, 25 Wells Fargo
    Equal-Weight
    Jul 9, 25 Piper Sandler
    Overweight
    Jun 30, 25 Guggenheim
    Buy
    May 9, 25 Jefferies
    Buy
    May 1, 25 Wells Fargo
    Equal-Weight
    May 1, 25 TD Securities
    Buy
    Feb 19, 25 Goldman Sachs
    Neutral
    Jan 7, 25 TD Cowen
    Buy
    Oct 30, 24 Wells Fargo
    Equal-Weight

    Institutional Ownership

    Screeners with WGS included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    High Piotroski score stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    • What is the ticker symbol for GeneDx Holdings Corp.?
    • Does GeneDx Holdings Corp. pay dividends?
    • What sector is GeneDx Holdings Corp. in?
    • What industry is GeneDx Holdings Corp. in?
    • What country is GeneDx Holdings Corp. based in?
    • When did GeneDx Holdings Corp. go public?
    • Is GeneDx Holdings Corp. in the S&P 500?
    • Is GeneDx Holdings Corp. in the NASDAQ 100?
    • Is GeneDx Holdings Corp. in the Dow Jones?
    • When was GeneDx Holdings Corp.'s last earnings report?
    • When does GeneDx Holdings Corp. report earnings?

    What is the ticker symbol for GeneDx Holdings Corp.?

    The ticker symbol for GeneDx Holdings Corp. is NASDAQ:WGS

    Does GeneDx Holdings Corp. pay dividends?

    No, GeneDx Holdings Corp. does not pay dividends

    What sector is GeneDx Holdings Corp. in?

    GeneDx Holdings Corp. is in the Healthcare sector

    What industry is GeneDx Holdings Corp. in?

    GeneDx Holdings Corp. is in the Diagnostics & Research industry

    What country is GeneDx Holdings Corp. based in?

    GeneDx Holdings Corp. is headquartered in United States

    When did GeneDx Holdings Corp. go public?

    GeneDx Holdings Corp.'s initial public offering (IPO) was on November 4, 2020

    Is GeneDx Holdings Corp. in the S&P 500?

    No, GeneDx Holdings Corp. is not included in the S&P 500 index

    Is GeneDx Holdings Corp. in the NASDAQ 100?

    No, GeneDx Holdings Corp. is not included in the NASDAQ 100 index

    Is GeneDx Holdings Corp. in the Dow Jones?

    No, GeneDx Holdings Corp. is not included in the Dow Jones index

    When was GeneDx Holdings Corp.'s last earnings report?

    GeneDx Holdings Corp.'s most recent earnings report was on July 29, 2025

    When does GeneDx Holdings Corp. report earnings?

    The next expected earnings date for GeneDx Holdings Corp. is October 28, 2025
    On this page